The pharma and biotech CRM software market presents key growth opportunities in AI-driven CRMs and cloud-based solutions, particularly for SMEs, pharma industries, and emerging markets like Asia ...

Operating a business today involves juggling sales pipelines, customer communications, and team projects, while not letting ...

Think of your CRM operating model as the blueprint for how your organization manages everything connected to your customer relationship system—the people, the processes, the data, and the technology ...

Microsoft Corporation is rated a Buy with strong fundamentals and robust AI-driven growth prospects. Learn more about MSFT ...

Palantir Technologies Inc. is a Strong Sell with excessive premium & growth deceleration leads to valuation contraction. Read ...

Salesforce, Inc. CRM stock looks attractive from a valuation perspective. CRM is currently trading at a forward 12-month ...

Diamond Hill Capital, an investment management company, released its “Select Fund” third-quarter 2025 investor letter. A copy ...

Through the new Microsoft Agent Framework, Azure’s agent factory touts an open-source software kit for devs to get to grips ...

Most organizations today run on dozens of tools. This includes CRMs, ERPs, analytics dashboards, and other cloud applications ...

Whoever wins in AI, wins the whole cake’ CoE focused on digital skills, talent development, performance to build trust Chin ...

A handful of high-flying technology stocks have led the stock market to new all-time highs in 2025, and the Technology Select Sector SPDR ETF (ticker: XLK) has significantly outperformed the S& ...

C3.ai stock craters on reports the company is considering a potential sale. Microsoft, Palantir, and Oracle could emerge as ...